Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Liver energy balance refers to the physiological maintenance of metabolic homeostasis within the liver, ensuring the coordination of energy acquisition, storage, and utilization in response to nutritional status. This process is primarily regulated by a network of nutrient-sensing nuclear receptors, most notably Peroxisome Proliferator-Activated Receptor alpha (PPARα) and Farnesoid X Receptor (FXR), which serve as sensors for fatty acids and bile acids. These regulators orchestrate the liver's transition between the fed state, focusing on lipogenesis and bile acid control, and the fasted state, characterized by fatty acid oxidation and gluconeogenesis. Dysregulation of liver energy balance is a central feature of metabolic disorders, including non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes, leading to excessive lipid accumulation and systemic insulin resistance. Therapeutic strategies aim to restore this balance by utilizing agonists for nuclear receptors or by modulating central metabolic hubs like AMPK. Successfully re-establishing liver energy balance is critical for mitigating hepatic inflammation and preventing the progression to advanced fibrosis or cirrhosis.
Modulation of liver energy balance is achieved by activating or inhibiting key metabolic regulators such as Peroxisome Proliferator-Activated Receptor alpha (PPARα), Farnesoid X Receptor (FXR), and AMP-activated protein kinase (AMPK), which coordinately regulate pathways including fatty acid oxidation, gluconeogenesis, and autophagy.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Liver energy balance.